|
1
|
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$487M
|
-$11.1M
|
-324,729
|
-3%
|
|
|
2
|
Crestline Management
Fort Worth,
Texas
|
$419M
|
-$274M
|
-8,033,393
|
-46%
|
|
|
3
|
Vanguard Group
Malvern,
Pennsylvania
|
$301M
|
+$14.7M
|
+430,077
|
+7%
|
|
|
4
|
Capital International Investors
Los Angeles,
California
|
$256M
|
+$195M
|
+5,714,198
|
New
|
|
|
5
|
|
$203M
|
+$8.2M
|
+240,488
|
+6%
|
|
|
6
|
State Street
Boston,
Massachusetts
|
$120M
|
-$19.3M
|
-565,261
|
-17%
|
|
|
7
|
Capital World Investors
Los Angeles,
California
|
$102M
|
-$5.11M
|
-150,000
|
-6%
|
|
|
8
|
BB Biotech
Schaffhausen,
Switzerland
|
$92.2M
|
-$4.43M
|
-130,000
|
-6%
|
|
|
9
|
|
$91.6M
|
+$38.4M
|
+1,126,400
|
+123%
|
|
|
10
|
Jennison Associates
New York
|
$89.2M
|
+$41.9M
|
+1,229,622
|
+162%
|
|
|
11
|
|
$87.9M
|
+$17.4M
|
+510,912
|
+35%
|
|
|
12
|
Biomark Capital Management
Greenwich,
Connecticut
|
$83.6M
|
–
|
–
|
–
|
|
|
13
|
Fidelity Investments
Boston,
Massachusetts
|
$78.5M
|
-$1.29M
|
-37,900
|
-2%
|
|
|
14
|
PFM Health Sciences
San Francisco,
California
|
$65.1M
|
+$45.5M
|
+1,335,912
|
+1,165%
|
|
|
15
|
ArrowMark Colorado Holdings
Denver,
Colorado
|
$58.9M
|
-$10.5M
|
-308,448
|
-19%
|
|
|
16
|
First Trust Advisors
Wheaton,
Illinois
|
$58.1M
|
-$494K
|
-14,485
|
-1%
|
|
|
17
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$50.7M
|
+$12.6M
|
+370,583
|
+49%
|
|
|
18
|
Omega Fund Management
Boston,
Massachusetts
|
$48.2M
|
-$5.28M
|
-154,900
|
-13%
|
|
|
19
|
|
$42.9M
|
+$31.2M
|
+915,730
|
+2,245%
|
|
|
20
|
|
$41.3M
|
+$1.82M
|
+53,296
|
+6%
|
|
|
21
|
Temasek Holdings
Singapore
|
$41.1M
|
–
|
–
|
–
|
|
|
22
|
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
$40.3M
|
-$126K
|
-3,710
|
-0.4%
|
|
|
23
|
Capital Guardian Trust
Los Angeles,
California
|
$37.4M
|
+$28.4M
|
+833,695
|
New
|
|
|
24
|
Janus Henderson Group
London,
|
$37.4M
|
+$28.4M
|
+832,611
|
New
|
|
|
25
|
Balyasny Asset Management
Chicago,
Illinois
|
$34M
|
+$19.9M
|
+582,986
|
+335%
|
|
